Cargando…
The Role of Lipolysis Stimulated Lipoprotein Receptor in Breast Cancer and Directing Breast Cancer Cell Behavior
The claudin-low molecular subtype of breast cancer is of particular interest for clinically the majority of these tumors are poor prognosis, triple negative, invasive ductal carcinomas. Claudin-low tumors are characterized by cancer stem cell-like features and low expression of cell junction and adh...
Autores principales: | Reaves, Denise K., Fagan-Solis, Katerina D., Dunphy, Karen, Oliver, Shannon D., Scott, David W., Fleming, Jodie M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956714/ https://www.ncbi.nlm.nih.gov/pubmed/24637461 http://dx.doi.org/10.1371/journal.pone.0091747 |
Ejemplares similares
-
Challenging the roles of CD44 and lipolysis stimulated lipoprotein receptor in conveying Clostridium perfringens iota toxin cytotoxicity in breast cancer
por: Fagan-Solis, Katerina D, et al.
Publicado: (2014) -
Hornerin, an S100 family protein, is functional in breast cells and aberrantly expressed in breast cancer
por: Fleming, Jodie M, et al.
Publicado: (2012) -
Role of Tricellular Tight Junction Protein Lipolysis-Stimulated Lipoprotein Receptor (LSR) in Cancer Cells
por: Kohno, Takayuki, et al.
Publicado: (2019) -
Anti-lipolysis-stimulated lipoprotein receptor monoclonal antibody as a novel therapeutic agent for endometrial cancer
por: Nagase, Yoshikazu, et al.
Publicado: (2022) -
Interaction of Clostridium perfringens Iota Toxin and Lipolysis-Stimulated Lipoprotein Receptor (LSR)
por: Nagahama, Masahiro, et al.
Publicado: (2018)